Table 4.
Outcomes | rs2583988 |
rs356219 |
rs2736990 |
||||||
---|---|---|---|---|---|---|---|---|---|
T allele (%) | OR (95%CI) | p | G allele (%) | OR (95%CI) | p | C allele (%) | OR (95%CI) | p | |
Age at onset | |||||||||
EOPD | 17 (23.0) | 1.24 (0.64–2.36) | 0.503 | 46 (62.0) | 1.82 (1.05–3.14) | 0.040 | 50 (68.0) | 1.88 (1.07–3.29) | 0.028 |
Controls | 38 (19.3) | 93 (47.4) | 79 (80.6) | ||||||
Cognitive impairment | |||||||||
PD | 34 (31.0) | 2.39 (1.25–4.58) | 0.010 | 72 (67.0) | 2.22 (1.29–3.84) | 0.004 | 76 (70.0) | 2.21(1.26–3.85) | 0.005 |
Controls | 18 (16.0) | 53 (47.0) | 58 (52.0) | ||||||
Anxiety | |||||||||
PD | 31 (23.0) | 1.29 (0.62–2.66) | 0.591 | 81 (60.0) | 1.47 (0.82–2.63) | 0.235 | 89 (65.0) | 1.63 (0.55–4.85) | 0.398 |
Controls | 13 (19.0) | 55 (40.0) | 38 (54.0) | ||||||
Depression | |||||||||
PD | 34 (24.0) | 1.31 (0.61–2.81) | 0.574 | 80 (57.0) | 1.24 (0.66–2.31) | 0.527 | 89 (64.0) | 1.59 (0.88–2.87) | 0.132 |
Controls | 11 (20.0) | 29 (52.0) | 32 (57.0) |
OR, odds ratio; CI, confidence interval; p, significance level; EOPD, early onset Parkinson’s disease; PD, Parkinson’s disease.